Akero Therapeutics Shares 2011-2026 | AKRO

Annual Shares Akero Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
67.1 M	52.6 M	39 M	34.8 M	34 M	15.1 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
67.1 M	15.1 M	40.4 M

Quarterly Shares Akero Therapeutics

2025-Q3	2025-Q2	2024-Q4	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
82 M	81.7 M	72.4 M	69.4 M	69.2 M	55.8 M	55.6 M	51.9 M	46.9 M	46.9 M	38.7 M	-	35 M	34.9 M	34.9 M	34.8 M	34.7 M	34.7 M	34 M	28.6 M	28.5 M	28.6 M	28 M	3.27 M	168 K	239 K	127 K	92.2 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
82 M	92.2 K	38.2 M

Shares of other stocks in the Biotechnology industry

Issuer	Shares	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	33.4 M	-	2.43 %	$ 254 M	Germany
Aligos Therapeutics ALGS	9.88 M	$ 8.64	8.07 %	$ 85.4 M	USA
Allakos ALLK	86.8 M	-	-	$ 28.6 M	USA
Alterity Therapeutics Limited ATHE	2.41 B	$ 3.66	-1.48 %	$ 8.81 B	Australia
Aptinyx APTX	67.7 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	36.4 M	-	-13.39 %	$ 1.45 M	USA
I-Mab IMAB	220 M	-	-	$ 866 M	China
AlloVir ALVR	15.3 M	-	4.14 %	$ 49.1 M	USA
Anavex Life Sciences Corp. AVXL	85.3 M	$ 3.11	-	$ 265 M	USA
Applied Molecular Transport AMTI	38.8 M	-	-	$ 10.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Genfit SA GNFT	44.7 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	118 M	-	-13.47 %	$ 169 M	France
Brainstorm Cell Therapeutics BCLI	9.27 M	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	84.2 M	-	-	$ 8.42 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
BeiGene, Ltd. BGNE	1.42 B	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	110 M	-	-	$ 546 M	USA
Midatech Pharma plc MTP	80.5 M	-	-18.52 %	$ 27.3 M	Britain
BioNTech SE BNTX	244 M	$ 96.7	-	$ 27.2 B	Germany
Burford Capital Limited BUR	219 M	$ 4.49	-	$ 731 M	Britain
Cabaletta Bio CABA	100 M	$ 3.2	-	$ 322 M	USA
Amphastar Pharmaceuticals AMPH	46.7 M	$ 21.36	-	$ 998 M	USA
Checkpoint Therapeutics CKPT	39.7 M	-	-	$ 169 M	USA
Институт стволовых клеток человека ISKJ	75 M	-	-	-	Russia
Adverum Biotechnologies ADVM	19.8 M	-	-	$ 86.2 M	USA
Advaxis ADXS	6.02 M	-	-9.65 %	$ 45.9 M	USA
Clearside Biomedical CLSD	61.8 M	-	-	$ 25.3 M	USA
Aeterna Zentaris AEZS	115 M	-	5.93 %	$ 314 M	Canada
CNS Pharmaceuticals CNSP	443 K	$ 2.51	-	$ 1.11 M	USA
AgeX Therapeutics AGE	10.2 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	78.2 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	257 M	$ 1.47	-	$ 378 M	USA
Precision BioSciences DTIL	3.84 M	$ 7.13	-	$ 27.4 M	USA
Applied Genetic Technologies Corporation AGTC	45 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	1.65 M	$ 2.92	-3.31 %	$ 4.81 M	Israel
Aquestive Therapeutics AQST	107 M	$ 4.19	-	$ 448 M	USA
Arcutis Biotherapeutics ARQT	127 M	$ 24.12	-	$ 3.07 B	USA
Chimerix CMRX	88.6 M	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	34.4 M	-	-	$ 401 M	USA
AIkido Pharma AIKI	14.3 M	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	66.4 M	$ 32.59	-	$ 2.16 B	USA
Autolus Therapeutics plc AUTL	266 M	$ 1.47	-	$ 391 M	Britain
Aptose Biosciences APTO	2.45 M	-	-45.71 %	$ 1.2 M	Canada
Cidara Therapeutics CDTX	6.35 M	-	-	$ 1.41 B	USA
AVROBIO AVRO	44.3 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	15.4 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	1.42 B	-	-	$ 96.9 B	Britain
CTI BioPharma Corp. CTIC	115 M	-	-	$ 1.2 B	USA